Transthyretin-directed RNA Interaction [EPC]

Transthyretin-directed RNA Interaction [EPC] was reported 175 times

Drugs of the Transthyretin-directed RNA Interaction [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 FLUID RESUSCITATION 1 0.5000
1 MAGNETIC RESONANCE IMAGING HEAD 1 0.1111
2 PROSTATIC ARTERY EMBOLISATION 1 0.0625
3 ACQUIRED ATTR AMYLOIDOSIS 2 0.0488
4 PREALBUMIN INCREASED 1 0.0455
5 VITAMIN A DECREASED 5 0.0323
6 GRANULAR CELL TUMOUR 1 0.0217
7 TUBERCULIN TEST 1 0.0204
8 AMYLOID ARTHROPATHY 1 0.0143
9 GLOMERULAR FILTRATION RATE 1 0.0137
10 VITAMIN A DEFICIENCY 1 0.0098
11 GLOMERULAR VASCULAR DISORDER 1 0.0067
12 RENAL NECROSIS 1 0.0046
13 BODY MASS INDEX ABNORMAL 1 0.0041
14 ANALGESIC THERAPY 1 0.0031
15 ARTERY DISSECTION 1 0.0024
16 CRANIAL NERVE PARALYSIS 1 0.0021
17 BRAIN NEOPLASM BENIGN 1 0.0020
18 AMYLOIDOSIS 3 0.0017
19 STOMACH MASS 1 0.0013
20 THYROID HORMONES DECREASED 1 0.0013
21 BLOOD ALBUMIN INCREASED 1 0.0011
22 PROTEIN URINE 1 0.0011
23 BONE CONTUSION 1 0.0011
24 SCROTAL SWELLING 1 0.0011
25 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
26 NIGHT BLINDNESS 1 0.0006
27 CARDIAC DISCOMFORT 1 0.0005
28 HEPATIC LESION 2 0.0005
29 VITAMIN B12 DECREASED 1 0.0003
30 HEPATITIS B 2 0.0003
31 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
32 MICTURITION DISORDER 1 0.0003
33 FACE INJURY 1 0.0003
34 MUSCLE RUPTURE 1 0.0003
35 VITAMIN B12 DEFICIENCY 1 0.0002
36 URINARY TRACT DISORDER 1 0.0002
37 VASCULAR DEVICE INFECTION 1 0.0002
38 RENAL FUNCTION TEST ABNORMAL 1 0.0002
39 SKIN ABRASION 1 0.0002
40 LIGAMENT SPRAIN 2 0.0002
41 ANORECTAL DISCOMFORT 1 0.0002
42 INJECTION SITE INJURY 1 0.0002
43 THERAPEUTIC RESPONSE CHANGED 1 0.0002
44 HYPERTRANSAMINASAEMIA 1 0.0001
45 NEUROPATHY PERIPHERAL 13 0.0001
46 MYOPATHY 1 0.0001
47 ASCITES 3 0.0001
48 VITREOUS FLOATERS 1 0.0001
49 THERAPY CHANGE 1 0.0001
50 BLADDER DISORDER 1 0.0001
51 EUPHORIC MOOD 1 0.0001
52 FULL BLOOD COUNT ABNORMAL 1 0.0001
53 ASPIRATION 1 0.0001
54 HAEMATURIA 3 0.0001
55 SEXUAL DYSFUNCTION 1 0.0001
56 POLYNEUROPATHY 1 0.0001
57 NOCTURIA 1 0.0001
58 NEURALGIA 2 0.0001
59 CYST 1 0.0001
60 IMPAIRED GASTRIC EMPTYING 1 0.0001
61 PARALYSIS 1 0.0001
62 PARAESTHESIA ORAL 1 0.0001
63 NEEDLE ISSUE 2 0.0001
64 APHASIA 2 0.0001
65 DEVICE RELATED INFECTION 1 0.0001
66 LIMB DISCOMFORT 2 0.0001
67 EJECTION FRACTION DECREASED 1 0.0001
68 SENSORY DISTURBANCE 1 0.0001
69 DEVICE USE ISSUE 1 0.0001
70 DRUG ERUPTION 1 0.0001
71 DYSURIA 2 0.0001
72 INCREASED APPETITE 1 0.0001
73 POST PROCEDURAL COMPLICATION 1 0.0001
74 GLAUCOMA 1 0.0001
75 INJURY ASSOCIATED WITH DEVICE 1 0.0000
76 IRRITABLE BOWEL SYNDROME 1 0.0000
77 MELAENA 1 0.0000
78 VISION BLURRED 6 0.0000
79 BURNING SENSATION 3 0.0000
80 CARDIAC DISORDER 4 0.0000
81 CEREBRAL INFARCTION 1 0.0000
82 HYPOAESTHESIA 6 0.0000
83 DIPLOPIA 1 0.0000
84 MUSCULOSKELETAL PAIN 2 0.0000
85 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
86 PARAESTHESIA 6 0.0000
87 BREAST CANCER FEMALE 1 0.0000
88 THROMBOSIS 3 0.0000
89 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
90 PAIN IN JAW 1 0.0000
91 INTENTIONAL DOSE OMISSION 1 0.0000
92 PLEURAL EFFUSION 2 0.0000
93 NERVOUS SYSTEM DISORDER 1 0.0000
94 MOVEMENT DISORDER 1 0.0000
95 DEEP VEIN THROMBOSIS 2 0.0000
96 BLOOD PRESSURE DECREASED 2 0.0000
97 FUNGAL INFECTION 1 0.0000
98 URINARY RETENTION 1 0.0000
99 HYPERKALAEMIA 1 0.0000
100 DEVICE MALFUNCTION 2 0.0000
101 DYSARTHRIA 1 0.0000
102 DISEASE PROGRESSION 3 0.0000
103 INJECTION SITE HAEMORRHAGE 2 0.0000
104 CARDIAC FAILURE 2 0.0000
105 EXTRA DOSE ADMINISTERED 1 0.0000
106 DEVICE BREAKAGE 1 0.0000
107 PRODUCT DOSE OMISSION ISSUE 7 0.0000
108 DEVICE LEAKAGE 1 0.0000
109 CONSTIPATION 5 0.0000
110 LIVER DISORDER 1 0.0000
111 GASTROINTESTINAL DISORDER 2 0.0000
112 MEMORY IMPAIRMENT 3 0.0000
113 COGNITIVE DISORDER 1 0.0000
114 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
115 OCULAR HYPERAEMIA 1 0.0000
116 PULMONARY EMBOLISM 2 0.0000
117 ATRIAL FIBRILLATION 2 0.0000
118 PAIN IN EXTREMITY 6 0.0000
119 DRY EYE 1 0.0000
120 SYNCOPE 2 0.0000
121 CELLULITIS 1 0.0000
122 FLUID RETENTION 1 0.0000
123 ILLNESS 2 0.0000
124 NERVOUSNESS 1 0.0000
125 DEATH 16 0.0000
126 CONFUSIONAL STATE 3 0.0000
127 RASH PRURITIC 1 0.0000
128 ARTHROPATHY 1 0.0000
129 INFLUENZA 2 0.0000
130 ABDOMINAL DISCOMFORT 3 0.0000
131 OXYGEN SATURATION DECREASED 1 0.0000
132 MUSCULAR WEAKNESS 2 0.0000
133 LETHARGY 1 0.0000
134 SURGERY 1 0.0000
135 WHEEZING 1 0.0000
136 FATIGUE 13 0.0000
137 JOINT SWELLING 2 0.0000
138 NAUSEA 13 0.0000
139 ANAEMIA 3 0.0000
140 DEHYDRATION 2 0.0000
141 INJECTION SITE PRURITUS 1 0.0000
142 VOMITING 7 0.0000
143 HEPATIC ENZYME INCREASED 1 0.0000
144 PAIN 9 0.0000
145 WEIGHT DECREASED 4 0.0000
146 MOBILITY DECREASED 1 0.0000
147 INFECTION 2 0.0000
148 DYSGEUSIA 1 0.0000
149 INJECTION SITE SWELLING 1 0.0000
150 PRURITUS 5 0.0000
151 PERIPHERAL SWELLING 2 0.0000
152 DRUG DOSE OMISSION BY DEVICE 1 0.0000
153 INJECTION SITE BRUISING 1 0.0000
154 FEELING ABNORMAL 3 0.0000
155 PROSTATE CANCER 1 0.0000
156 DRY MOUTH 1 0.0000
157 URTICARIA 2 0.0000
158 RENAL IMPAIRMENT 1 0.0000
159 URINARY TRACT INFECTION 2 0.0000
160 BALANCE DISORDER 1 0.0000
161 MUSCULOSKELETAL STIFFNESS 1 0.0000
162 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
163 MUSCLE SPASMS 2 0.0000
164 ADVERSE EVENT 1 0.0000
165 HYPERSENSITIVITY 2 0.0000
166 SWELLING 1 0.0000
167 DYSPEPSIA 1 0.0000
168 HEART RATE INCREASED 1 0.0000
169 ABDOMINAL PAIN UPPER 2 0.0000
170 ABDOMINAL DISTENSION 1 0.0000
171 DIARRHOEA 6 0.0000
172 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
173 MALAISE 4 0.0000
174 FALL 3 0.0000
175 SEPSIS 1 0.0000
176 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
177 CHILLS 1 0.0000
178 OEDEMA PERIPHERAL 1 0.0000
179 VISUAL IMPAIRMENT 1 0.0000
180 DIZZINESS 4 0.0000
181 RENAL FAILURE 1 0.0000
182 ARTHRALGIA 3 0.0000
183 ACUTE KIDNEY INJURY 1 0.0000
184 CHEST PAIN 1 0.0000
185 PRODUCT USE ISSUE 1 0.0000
186 BLOOD GLUCOSE INCREASED 1 0.0000
187 SOMNOLENCE 1 0.0000
188 ERYTHEMA 1 0.0000
189 HYPERTENSION 1 0.0000
190 RASH 2 0.0000
191 WEIGHT INCREASED 1 0.0000
192 DEPRESSION 1 0.0000
193 INCORRECT DOSE ADMINISTERED 1 0.0000
194 DECREASED APPETITE 1 0.0000
195 BACK PAIN 1 0.0000
196 DRUG INEFFECTIVE 5 0.0000
197 CONDITION AGGRAVATED 1 0.0000
198 INJECTION SITE PAIN 1 0.0000
199 ASTHENIA 1 0.0000
200 DYSPNOEA 1 0.0000